Gilead

Gilead Sciences Inc. is a biopharmaceutical company that has pursued and achieved break-throughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer, Gilead operates in more than 35 counties worldwide, with headquarters in Foster City, California.

Gilead and the Gilead logo are trademarks of Gilead Sciences Inc.

Merck

Merck’s Commitment to HIV

For more than 35 years, Merck has been committed to scientific research and discovery in HIV. Today, we are developing a series of antiviral options designed to help people manage HIV and protect people from HIV, with the goal of reducing the growing burden of infection worldwide. We remain committed to collaborating with others in the global HIV community to address the complex challenges that impede progress toward ending the epidemic.

ViiV

We are ViiV Healthcare: here until HIV & AIDS are not.

Proud to support #HIVGlasgow2024, we are the only company 100% solely focused on combating, preventing and ultimately curing HIV and AIDS.
 
Scientific breakthroughs underpin our diverse portfolio
Our innovative pipeline and diverse portfolio of medicines are completely focused on addressing the changing wants and needs of people living with and impacted by HIV.
#WeWontStop at treatment and are committed to finding a cure for HIV.
 
Leaving no person living with HIV behind
Together with our partners, we are committed to driving innovative approaches to improving access to medicines for people living with and impacted by HIV around the world.
Through our Positive Action programme, we have supported over 300 projects worldwide with the aim of achieving healthy communities in a world free of HIV and AIDS.
 
We are proud to be a major industry partner of HIV Glasgow 2024 where we stand with the HIV community, calling on the world to come together to re-engage and follow the science.
 
Read more about us at viivhealthcare.com and follow us on social media.

Janssen Pharmaceutica NV

Please visit: www.janssen.com/emea/

Virology Education

Virology Education and Academic Medical Education are committed to facilitating medical education to both healthcare professionals and the patient communities in the fields of HIV, hepatitis, COVID-19, liver disease, and more to develop these disciplines and support communities with continuing education.

With this clear mission and drive to keep education accessible and inclusive to all professionals who wish to participate, we operate all over the world and produce medical programs in English, Spanish, Portuguese, Mandarin Chinese, Russian, amongst several other languages.

We strive to have a diverse and informed group of speakers and participants to enable knowledge sharing and networking across various fields and specialities. By including speakers and engaging participants from all ethnicities, ages, geographic locations, and genders, we aim to ensure that the knowledge disseminated in our programs is all-encompassing, meeting the wide-ranging needs of the global healthcare community.

As we continue to develop our portfolio of medical education programs, our goal is to revisit our curricula to ensure that each program’s primary focus is to address the most urgent medical education needs and simultaneously assess the delivery format to ensure the greatest impact.

With this winning combination of learning from our feedback and leveraging our network of key opinion leaders, we strive to derive the highest-quality content into concise but comprehensive learning via online education, hybrid meetings for small and large groups, and enduring materials.